KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Emergent BioSolutions (EBS) Operating Expenses: 2010-2024

Historic Operating Expenses for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to $1.2 billion.

  • Emergent BioSolutions' Operating Expenses fell 32.58% to $154.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $670.4 million, marking a year-over-year decrease of 47.15%. This contributed to the annual value of $1.2 billion for FY2024, which is 35.11% down from last year.
  • According to the latest figures from FY2024, Emergent BioSolutions' Operating Expenses is $1.2 billion, which was down 35.11% from $1.8 billion recorded in FY2023.
  • In the past 5 years, Emergent BioSolutions' Operating Expenses registered a high of $1.8 billion during FY2023, and its lowest value of $1.1 billion during FY2020.
  • Its 3-year average for Operating Expenses is $1.4 billion, with a median of $1.3 billion in 2022.
  • Its Operating Expenses has fluctuated over the past 5 years, first spiked by 37.92% in 2023, then tumbled by 35.11% in 2024.
  • Over the past 5 years, Emergent BioSolutions' Operating Expenses (Yearly) stood at $1.1 billion in 2020, then increased by 25.76% to $1.4 billion in 2021, then declined by 10.10% to $1.3 billion in 2022, then soared by 37.92% to $1.8 billion in 2023, then crashed by 35.11% to $1.2 billion in 2024.